Skip to main content
main-content

EULAR 2020 E-Congress

3 JUNE 2020 – 6 JUNE 2020

Top trending from EULAR 2020 E-Congress

COVID-19 hospitalization: What do the data tell us?

A round-up of the data presented at the EULAR 2020 E-Congress with additional commentary provided by Pedro Machado.

SELECT-CHOICE study results

The latest news on upadacitinib versus abatacept in this head-to-head rheumatoid arthritis trial.

SELECT-PsA-1 and SELECT-PsA-2: Upadacitinib shows promise for PsA

The latest news on these trials with additional commentary provided by Alexis Ogdie and lead investigator Philip Mease. 

Congress highlights from the Editorial Board

12-06-2020 | EULAR 2020 | Conference coverage | Video

EULAR 2020 highlights: Fernando Pérez-Ruiz

Fernando Pérez-Ruiz discusses some of the key gout and crystal arthritis studies presented at the EULAR 2020 E-Congress (8:10).

10-06-2020 | EULAR 2020 | Conference coverage | Video

EULAR 2020 highlights: Oliver FitzGerald

Oliver FitzGerald outlines his highlights from the psoriatic arthritis presentations at the EULAR 2020 E-Congress, and discusses what the study results mean for clinical practice (10:13).

Latest news from EULAR 2020 E-Congress

Expert interviews from EULAR 2020 E-Congress

09-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: The JAKPOT study

Kim Lauper discusses findings from the JAKPOT study, an international collaboration showing comparable JAK inhibitor and TNF inhibitor retention rates in real-world patients with rheumatoid arthritis (3:50).

09-06-2020 | EULAR 2020 | Conference coverage | Video

Expert commentary: The SELECT-PsA-1 and SELECT-PsA-2 trials

Alexis Ogdie comments on the results of two phase 3 trials demonstrating the potential of upadacitinib as a treatment option for psoriatic arthritis patients with and without prior exposure to biologic agents (3:59).

06-06-2020 | EULAR 2020 | Conference coverage | Video

Expert commentary: VTE in patients with RA

John Isaacs comments on two studies on venous thromboembolism in patients with rheumatoid arthritis, highlighting the robustness of the findings and what they mean for patient management (5:47).

04-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: The CONTROL trial

04-06-2020 | EULAR 2020 conference hub | Conference coverage | Video

Expert commentary: The EXCEED trial

04-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: The ADVOCATE trial

05-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: The EXCEED trial

05-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: The BLISS-LN trial

05-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: SELECT-PsA-1

06-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: SELECT-PsA-2


Medicine Matters conference coverage is brought to you in partnership with medwireNews


Image Credits